Eradication of Malignant Carcinoma in the Breast Tissue
Conditions
Breast Cancer
Study Type
Interventional
Study Phase
Phase 2/Phase 3
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Intervention
Name: Acetogenins Type: Dietary Supplement
Name: Placebo Type: Dietary Supplement
Overall Status
Not yet recruiting
Summary
The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 75 Years
Minimum Age: 35 Years
Gender: Female
Criteria: Inclusion Criteria:

- Clinical diagnosis of breast cancer

- Referred to the study by their treating physician

Exclusion Criteria:

- Any type of treatment for breast cancer before starting the study
Location
Start Date
July 2015
Completion Date
March 2017
Sponsors
Optimal Health Research
Source
Optimal Health Research
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page